A
1.26
0.00 (0.00%)
| Previous Close | 1.26 |
| Open | 1.23 |
| Volume | 166,512 |
| Avg. Volume (3M) | 2,052,185 |
| Market Cap | 19,380,816 |
| Price / Sales | 205.85 |
| Price / Book | 1.58 |
| 52 Weeks Range |
| Operating Margin (TTM) | -5,822.92% |
| Diluted EPS (TTM) | -2.89 |
| Quarterly Revenue Growth (YOY) | 75.60% |
| Total Debt/Equity (MRQ) | 149.87% |
| Current Ratio (MRQ) | 2.89 |
| Operating Cash Flow (TTM) | -29.93 M |
| Levered Free Cash Flow (TTM) | -28.82 M |
| Return on Assets (TTM) | -82.76% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | Adagio Medical Holdings, Inc | - | - |
AIStockmoo Score
-1.8
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -3.0 |
| Average | -1.75 |
|
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| % Held by Insiders | 0.29% |
| % Held by Institutions | 85.46% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 15 May 2025 | Announcement | Adagio Medical Reports First Quarter 2025 Results |
| 07 May 2025 | Announcement | Adagio Medical to Present at the BofA Securities 2025 Health Care Conference |
| 17 Apr 2025 | Announcement | Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System |
| 31 Mar 2025 | Announcement | Adagio Medical Reports Fourth Quarter and Full Year 2024 Results |
| 31 Mar 2025 | Announcement | Adagio Medical Appoints Deborah Kaster as Chief Business Officer |
| 17 Mar 2025 | Announcement | Adagio Medical Provides Clinical and Business Updates |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |